Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection

被引:324
|
作者
Planche, Timothy D. [1 ,2 ]
Davies, Kerrie A. [3 ,4 ]
Coen, Pietro G. [7 ]
Finney, John M. [5 ,6 ]
Monahan, Irene M. [1 ,2 ]
Morris, Kirsti A. [3 ,4 ]
O'Connor, Lily [5 ,6 ]
Oakley, Sarah J. [5 ,6 ]
Pope, Cassie F. [1 ,2 ]
Wren, Mike W. [7 ,8 ]
Shetty, Nandini P. [7 ,8 ]
Crook, Derrick W. [5 ,6 ]
Wilcox, Mark H. [3 ,4 ]
机构
[1] Univ London, Ctr Infect & Immun, Div Clin Med, London, England
[2] St Georges Healthcare NHSTrust, Dept Med Microbiol, London, England
[3] Leeds Teaching Hosp NHSTrust, Dept Microbiol, Leeds LS1 3EX, W Yorkshire, England
[4] Univ Leeds, Leeds, W Yorkshire, England
[5] Oxford Univ Hosp NHSTrust, Oxford, England
[6] Oxford Univ Hosp NHSTrust, NIHR OxBRC Infect Theme, Oxford, England
[7] Univ Coll London Hosp NHS Fdn Trust, London, England
[8] Hlth Protect Agcy, Dept Clin Microbiol & Virol, London, England
来源
LANCET INFECTIOUS DISEASES | 2013年 / 13卷 / 11期
关键词
GLUTAMATE-DEHYDROGENASE; LABORATORY DIAGNOSIS; TOXIN; DIARRHEA; DISEASE; ALGORITHM; CULTURE; GUIDELINES; STRAIN; IMPACT;
D O I
10.1016/S1473-3099(13)70200-7
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background Diagnosis of Clostridium difficile infection is controversial because of many laboratory methods, compounded by two reference methods. Cytotoxigenic culture detects toxigenic C difficile and gives a positive result more frequently (eg, because of colonisation, which means that individuals can have the bacterium but no free toxin) than does the cytotoxin assay, which detects preformed toxin in faeces. We aimed to validate the reference methods according to clinical outcomes and to derive an optimum laboratory diagnostic algorithm for C difficile infection. Methods In this prospective, multicentre study, we did cytotoxigenic culture and cytotoxin assays on 12 420 faecal samples in four UK laboratories. We also performed tests that represent the three main targets for C difficile detection: bacterium (glutamate dehydrogenase), toxins, or toxin genes. We used routine blood test results, length of hospital stay, and 30-day mortality to clinically validate the reference methods. Data were categorised by reference method result: group 1, cytotoxin assay positive; group 2, cytotoxigenic culture positive and cytotoxin assay negative; and group 3, both reference methods negative. Findings Clinical and reference assay data were available for 6522 inpatient episodes. On univariate analysis, mortality was significantly higher in group 1 than in group 2 (72/435 [16.6%] vs 20/207 [9.7%], p=0.044) and in group 3 (503/5880 [8.6%], p<0.001), but not in group 2 compared with group 3 (p=0.4). A multivariate analysis accounting for potential confounders confirmed the mortality differences between groups 1 and 3 (OR 1.61, 95% CI 1.12-2.31). Multistage algorithms performed better than did standalone assays. Interpretation We noted no increase in mortality when toxigenic C difficile alone was present. Toxin (cytotoxin assay) positivity correlated with clinical outcome, and so this reference method best defines true cases of C difficile infection. A new diagnostic category of potential C difficile excretor (cytotoxigenic culture positive but cytotoxin assay negative) could be used to characterise patients with diarrhoea that is probably not due to C difficile infection, but who can cause cross-infection.
引用
下载
收藏
页码:936 / 945
页数:10
相关论文
共 50 条
  • [41] Evaluation of real-time PCR and conventional diagnostic methods for the detection of Clostridium difficile-associated diarrhoea in a prospective multicentre study
    van den Berg, Renate J.
    Vaessen, Norbert
    Endtz, Hubert P.
    Schulin, Tanja
    van der Vorm, Eric R.
    Kuijper, Ed J.
    JOURNAL OF MEDICAL MICROBIOLOGY, 2007, 56 (01) : 36 - 42
  • [42] Prediction of poor outcome in Clostridioides difficile infection: A multicentre external validation of the toxin B amplification cycle
    Reigadas, E.
    Alcala, L.
    Marin, M.
    Martin, A.
    Munoz, P.
    Bouza, E.
    ANAEROBE, 2020, 61
  • [43] Prevalence of Clostridium Difficile-Associated Diarrhoea in Hospitalised Patients (Results of a Russian Prospective Multicentre Study)
    Natalia V. Dmitrieva
    Galina A. Klyasova
    Natalia V. Bakulina
    Marina A. Sukhina
    Sergey V. Zhuravel
    Elena A. Belousova
    Vladimir T. Ivashkin
    Sergey V. Goryunov
    Elena A. Prokhorovich
    Tatyana R. Kameneva
    Aleksey A. Samsonov
    Andrey V. Yakovenko
    Stanislav V. Kazakov
    Infectious Diseases and Therapy, 2018, 7 : 523 - 534
  • [44] A Multi-Center Prospective Derivation and Validation of a Clinical Prediction Tool for Severe Clostridium difficile Infection
    Na, Xi
    Martin, Alan J.
    Sethi, Saurabh
    Kyne, Lorraine
    Garey, Kevin W.
    Flores, Sarah W.
    Hu, Mary
    Shah, Dhara N.
    Shields, Kelsey
    Leffler, Daniel A.
    Kelly, Ciaran P.
    PLOS ONE, 2015, 10 (04):
  • [45] Prevalence of Clostridium Difficile-Associated Diarrhoea in Hospitalised Patients (Results of a Russian Prospective Multicentre Study)
    Dmitrieva, Natalia V.
    Klyasova, Galina A.
    Bakulina, Natalia V.
    Sukhina, Marina A.
    Zhuravel, Sergey V.
    Belousova, Elena A.
    Ivashkin, Vladimir T.
    Goryunov, Sergey V.
    Prokhorovich, Elena A.
    Kameneva, Tatyana R.
    Samsonov, Aleksey A.
    Yakovenko, Andrey V.
    Kazakov, Stanislav V.
    INFECTIOUS DISEASES AND THERAPY, 2018, 7 (04) : 523 - 534
  • [46] Clostridium difficile Testing Algorithms Using Glutamate Dehydrogenase Antigen and C. difficile Toxin Enzyme Immunoassays with C. difficile Nucleic Acid Amplification Testing Increase Diagnostic Yield in a Tertiary Pediatric Population
    Ota, Kaede V.
    McGowan, Karin L.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (04) : 1185 - 1188
  • [47] Prospective Study to Reduce Clostridium Difficile Infection in Patients Receiving Autologous Stem Cell Transplantation
    Maldonado, Samuel David, Jr.
    Van Galen, Joseph
    Grose, Kyle
    Keng, Michael K.
    Volodin, Leonid
    BLOOD, 2021, 138 : 1899 - +
  • [48] USE OF PROPHYLACTIC SACCHAROMYCES BOULARDI I TO PREVENT CLOSTRIDIUM DIFFICILE INFECTION: A PROSPECTIVE INTERVENTION STUDY
    Carstensen, Jeppe W.
    Chehri, Mahtab
    Schonning, Kristian
    Rasmussen, Steen C.
    Anhoj, Jacob
    Andersen, Christian
    Petersen, Andreas M.
    GASTROENTEROLOGY, 2017, 152 (05) : S345 - S345
  • [49] ICU-Onset Clostridium difficile Infection in a University Hospital in China: A Prospective Cohort Study
    Wang, Xiaohui
    Cai, Lin
    Yu, Rujia
    Huang, Wenzhi
    Zong, Zhiyong
    PLOS ONE, 2014, 9 (11):
  • [50] Is Clostridium difficile infection a real threat in patients with ulcerative colitis? A prospective, multicenter study in Korea
    Kim, Dae Bum
    Lee, Kang-Moon
    Park, Sang Hyoung
    Kim, You Sun
    Kim, Eun Soo
    Lee, Jun
    Jung, Sung-Ae
    Seo, Geom Seog
    Lee, Ji Min
    INTESTINAL RESEARCH, 2018, 16 (02) : 267 - 272